Cisplatin–epirubicin–paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group

1999 ◽  
Vol 56 (3) ◽  
pp. 237-250 ◽  
Author(s):  
Giuseppe Frasci ◽  
Giuseppe D'Aiuto ◽  
Pasquale Comella ◽  
Anna Apicella ◽  
Renato Thomas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Phase I Study ◽  
Southern Italy ◽  
Advanced Breast ◽  
Oncology Group ◽  
Weekly Administration

scholarly journals Phase I study of QLNC120, a novel EGFR and HER2 kinase inhibitor, in pre-treated patients with HER2-overexpressing advanced breast cancer

Oncotarget ◽  
2016 ◽  
Vol 8 (22) ◽  
pp. 36750-36760 ◽  
Author(s):  
Tongtong Zhang ◽  
Qing Li ◽  
Shanshan Chen ◽  
Yang Luo ◽  
Ying Fan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Phase I Study ◽  
Kinase Inhibitor ◽  
Advanced Breast

The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics

2008 ◽  
Vol 44 (1) ◽  
pp. 84-91 ◽  
Author(s):  
Ahmad Awada ◽  
Fatima Cardoso ◽  
Christel Fontaine ◽  
Luc Dirix ◽  
Jacques De Grève ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Phase I Study ◽  
Mtor Inhibitor ◽  
Advanced Breast

scholarly journals A Phase I Study of Lde225 in Combination with Docetaxel in Patients with Triple Negative (Tn) Advanced Breast Cancer (Abc): Geicam/2012-12

2014 ◽  
Vol 25 ◽  
pp. iv135 ◽  
Author(s):  
M. Martin ◽  
M. Ruiz-Borrego ◽  
J.M. Trigo ◽  
S. Antolin ◽  
J.A. Garcia Saenz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Phase I Study ◽  
Triple Negative ◽  
Advanced Breast

Phase I Study of Vinorelbine and Carboplatin Combination in Patients with Taxane and Anthracycline Pretreated Advanced Breast Cancer

Oncology ◽  
2002 ◽  
Vol 62 (2) ◽  
pp. 103-109 ◽  
Author(s):  
C. Kosmas ◽  
S. Agelaki ◽  
T. Giannakakis ◽  
D. Mavroudis ◽  
Ch. Kouroussis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Phase I Study ◽  
Advanced Breast

scholarly journals A phase I study of sonidegib (S) in combination with docetaxel (D) in patients (pts) with triple negative (TN) advanced breast cancer (ABC): GEICAM/2012-12 (EDALINE study)

2016 ◽  
Vol 27 ◽  
pp. vi87 ◽  
Author(s):  
M. Martín ◽  
M. Ruiz-Borrego ◽  
J.M. Trigo Perez ◽  
S. Antolín ◽  
J.A. García-Sáenz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Phase I Study ◽  
Triple Negative ◽  
Advanced Breast
Sign in / Sign up

Export Citation Format

Share Document